Lexicon Pharma (LXRX), Ipsen Enter Agreement for Telotristat Etiprate Commercialization in Canada
Tweet Send to a Friend
Lexicon Pharma (NASDAQ: LXRX) and Ipsen S.A. announced that they have entered into an agreement for Ipsen, upon regulatory approval ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
